{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:10:17Z","timestamp":1790727017313,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204704"],"award-info":[{"award-number":["82204704"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515010480"],"award-info":[{"award-number":["2024A1515010480"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2019B030302005"],"award-info":[{"award-number":["2019B030302005"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"DOI":"10.1007\/s00592-025-02492-5","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T13:52:14Z","timestamp":1743688334000},"page":"1621-1630","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["FTZ alleviates lipid deposition in diabetic kidney disease by AMPK\/ACC\/SREBP signaling pathway"],"prefix":"10.1007","volume":"62","author":[{"given":"Jie","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Bo","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0116-3827","authenticated-orcid":false,"given":"Yi-Qi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"issue":"7","key":"2492_CR1","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/aps.2015.23","volume":"36","author":"J Jin","year":"2015","unstructured":"Jin J, Peng C, Wu SZ, Chen HM, Zhang BF (2015) Blocking VEGF\/Caveolin-1 signaling contributes to renal protection of fasudil in streptozotocin-induced diabetic rats [J]. Acta Pharmacol Sin 36(7):831\u2013840","journal-title":"Acta Pharmacol Sin"},{"key":"2492_CR2","doi-asserted-by":"crossref","unstructured":"Van Raalte DH, Bjornstad P, Cherney DZI, De Boer IH, Fioretto P, Gordin D et al (2024) Combination therapy for kidney disease in people with diabetes mellitus [J]. Nat Rev Nephrol 20(7):433\u2013446","DOI":"10.1038\/s41581-024-00827-z"},{"issue":"1","key":"2492_CR3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12916-022-02539-2","volume":"20","author":"T Forst","year":"2022","unstructured":"Forst T, Mathieu C, Giorgino F, Wheeler DC, Papanas N, Schmieder RE et al (2022) New strategies to improve clinical outcomes for diabetic kidney disease [J]. BMC Med 20(1):337","journal-title":"BMC Med"},{"key":"2492_CR4","doi-asserted-by":"crossref","unstructured":"Weinberg JM (2006) Lipotoxicity [J]. Kidney Int 70(9):1560\u20131566","DOI":"10.1038\/sj.ki.5001834"},{"issue":"1","key":"2492_CR5","doi-asserted-by":"crossref","first-page":"F263","DOI":"10.1152\/ajprenal.00171.2010","volume":"300","author":"C Tovar-Palacio","year":"2011","unstructured":"Tovar-Palacio C, Tovar AR, Torres N, Cruz C, Hernandez-Pando R, Salas-Garrido G et al (2011) Proinflammatory gene expression and renal lipogenesis are modulated by dietary protein content in obese Zucker Fa\/fa rats [J]. Am J Physiol Ren Physiol 300(1):F263\u2013F271","journal-title":"Am J Physiol Ren Physiol"},{"issue":"1","key":"2492_CR6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41419-019-2219-4","volume":"11","author":"Q Ke","year":"2020","unstructured":"Ke Q, Yuan Q, Qin N, Shi C, Luo J, Fang Y et al (2020) UCP2-induced hypoxia promotes lipid accumulation and tubulointerstitial fibrosis during ischemic kidney injury [J]. Cell Death Dis 11(1):26","journal-title":"Cell Death Dis"},{"key":"2492_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2023.07.004","volume":"266","author":"S Lin","year":"2024","unstructured":"Lin S, Wang L, Jia Y, Sun Y, Qiao P, Quan Y et al (2024) Lipin-1 deficiency deteriorates defect of fatty acid beta-oxidation and lipid-related kidney damage in diabetic kidney disease [J]. Transl Res 266:1\u201315","journal-title":"Transl Res"},{"issue":"3","key":"2492_CR8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1194\/jlr.P040501","volume":"55","author":"M Herman-Edelstein","year":"2014","unstructured":"Herman-Edelstein M, Scherzer P, Tobar A, Levi M, Gafter U (2014) Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy [J]. J Lipid Res 55(3):561\u2013572","journal-title":"J Lipid Res"},{"issue":"12","key":"2492_CR9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41581-018-0072-9","volume":"14","author":"CJ Ferro","year":"2018","unstructured":"Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P et al (2018) Lipid management in patients with chronic kidney disease [J]. Nat Rev Nephrol 14(12):727\u2013749","journal-title":"Nat Rev Nephrol"},{"key":"2492_CR10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3389\/fendo.2019.00459","volume":"10","author":"Y Huang","year":"2019","unstructured":"Huang Y, Xu J, Wu X, Chen X, Bai X, Zhuang Y et al (2019) High expression of complement components in the kidneys of type 2 diabetic rats with diabetic nephropathy [J]. Front Endocrinol (Lausanne) 10:459","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2492_CR11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig S, Shaw RJ (2018) AMPK: guardian of metabolism and mitochondrial homeostasis [J]. Nat Rev Mol Cell Biol 19(2):121\u2013135","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"2492_CR12","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","volume":"7","author":"JA Menendez","year":"2007","unstructured":"Menendez JA, Lupu R (2007) Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis [J]. Nat Rev Cancer 7(10):763\u2013777","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"2492_CR13","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.cmet.2024.02.004","volume":"36","author":"S Deja","year":"2024","unstructured":"Deja S, Fletcher JA, Kim CW, Kucejova B, Fu X, Mizerska M et al (2024) Hepatic malonyl-CoA synthesis restrains gluconeogenesis by suppressing fat oxidation, pyruvate carboxylation, and amino acid availability [J]. Cell Metab 36(5):1088\u2013 104.e12","journal-title":"Cell Metab"},{"issue":"1","key":"2492_CR14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2005.12.022","volume":"124","author":"JL Goldstein","year":"2006","unstructured":"Goldstein JL, Debose-Boyd RA, Brown MS (2006) Protein sensors for membrane sterols [J]. Cell 124(1):35\u201346","journal-title":"Cell"},{"issue":"9","key":"2492_CR15","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","volume":"109","author":"JD Horton","year":"2002","unstructured":"Horton JD, Goldstein JL, Brown MS (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver [J]. J Clin Invest 109(9):1125\u20131131","journal-title":"J Clin Invest"},{"key":"2492_CR16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1479-5876-12-47","volume":"12","author":"X Hu","year":"2014","unstructured":"Hu X, Wang M, Bei W, Han Z, Guo J (2014) The Chinese herbal medicine FTZ attenuates insulin resistance via IRS1 and PI3K in vitro and in rats with metabolic syndrome [J]. J Transl Med 12:47","journal-title":"J Transl Med"},{"key":"2492_CR17","doi-asserted-by":"crossref","first-page":"111343","DOI":"10.1016\/j.biopha.2021.111343","volume":"137","author":"L Song","year":"2021","unstructured":"Song L, Zhang D, Guo C, Gu Z, Wang L, Yao YS et al (2021) The traditional Chinese medicine formula Fufang-Zhenzhu-Tiaozhi protects myocardia from injury in diabetic minipigs with coronary heart disease [J]. Biomed Pharmacother 137:111343","journal-title":"Biomed Pharmacother"},{"key":"2492_CR18","doi-asserted-by":"crossref","first-page":"111060","DOI":"10.1016\/j.biopha.2020.111060","volume":"133","author":"J Cai","year":"2021","unstructured":"Cai J, Zhang J, Li S, Lin Y, Xiao X, Guo J (2021) Comprehensive chemical analysis of Zhenshu Tiaozhi formula and its effect on ameliorating glucolipid metabolic disorders in diabetic rats [J]. Biomed Pharmacother 133:111060","journal-title":"Biomed Pharmacother"},{"key":"2492_CR19","doi-asserted-by":"crossref","first-page":"114919","DOI":"10.1016\/j.biopha.2023.114919","volume":"164","author":"M Yan","year":"2023","unstructured":"Yan M, Liu S, Zeng W, Guo Q, Mei Y, Shao X et al (2023) The Chinese herbal medicine Fufang Zhenzhu Tiaozhi ameliorates diabetic cardiomyopathy by regulating cardiac abnormal lipid metabolism and mitochondrial dynamics in diabetic mice [J]. Biomed Pharmacother 164:114919","journal-title":"Biomed Pharmacother"},{"key":"2492_CR20","doi-asserted-by":"crossref","first-page":"154935","DOI":"10.1016\/j.phymed.2023.154935","volume":"118","author":"T Lan","year":"2023","unstructured":"Lan T, Tang T, Li Y, Duan Y, Yuan Q, Liu W et al (2023) FTZ polysaccharides ameliorate kidney injury in diabetic mice by regulating gut-kidney axis [J]. Phytomedicine 118:154935","journal-title":"Phytomedicine"},{"key":"2492_CR21","doi-asserted-by":"crossref","first-page":"116564","DOI":"10.1016\/j.jep.2023.116564","volume":"315","author":"Q Zhong","year":"2023","unstructured":"Zhong Q, Yin J, Wang K, Chen X, Wang H, Hu X et al (2023) FTZ promotes islet beta-cell regeneration in T1DM mice via the regulation of nuclear proliferation factors [J]. J Ethnopharmacol 315:116564","journal-title":"J Ethnopharmacol"},{"key":"2492_CR22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cbi.2019.05.004","volume":"307","author":"S Ding","year":"2019","unstructured":"Ding S, Qiu H, Huang J, Chen R, Zhang J, Huang B et al (2019) Activation of 20-HETE\/PPARs involved in reno-therapeutic effect of naringenin on diabetic nephropathy [J]. Chem Biol Interact 307:116\u2013124","journal-title":"Chem Biol Interact"},{"issue":"6","key":"2492_CR23","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1681\/ASN.2019101029","volume":"31","author":"YJ Li","year":"2020","unstructured":"Li YJ, Chen X, Kwan TK, Loh YW, Singer J, LIU Y et al (2020) Dietary fiber protects against diabetic nephropathy through short-chain fatty acid-mediated activation of G Protein-coupled receptors GPR43 and GPR109A [J]. J Am Soc Nephrol 31(6):1267\u20131281","journal-title":"J Am Soc Nephrol"},{"key":"2492_CR24","doi-asserted-by":"crossref","first-page":"101548","DOI":"10.1016\/j.redox.2020.101548","volume":"34","author":"MR Noh","year":"2020","unstructured":"Noh MR, Kong MJ, Han SJ, Kim JI, Park KM (2020) Isocitrate dehydrogenase 2 deficiency aggravates prolonged high-fat diet intake-induced hypertension [J]. Redox Biol 34:101548","journal-title":"Redox Biol"},{"key":"2492_CR25","doi-asserted-by":"crossref","first-page":"154988","DOI":"10.1016\/j.phymed.2023.154988","volume":"119","author":"Z Liu","year":"2023","unstructured":"Liu Z, Shang Q, Li H, Fang D, Li Z, Huang Y et al (2023) Exploring the possible mechanism(s) underlying the nephroprotective effect of Zhenwu Decoction in diabetic kidney disease: an integrated analysis [J]. Phytomedicine 119:154988","journal-title":"Phytomedicine"},{"key":"2492_CR26","doi-asserted-by":"crossref","unstructured":"Sun ZJ, Chang DY, Chen M, Zhao MH (2022) Deficiency of CFB attenuates renal tubulointerstitial damage by inhibiting ceramide synthesis in diabetic kidney disease [J]. JCI Insight, 7(24):e156748","DOI":"10.1172\/jci.insight.156748"},{"issue":"11","key":"2492_CR27","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.2337\/dc11-0475","volume":"34","author":"GA Nichols","year":"2011","unstructured":"Nichols GA, Vupputuri S, Lau H (2011) Medical care costs associated with progression of diabetic nephropathy [J]. Diabetes Care 34(11):2374\u20132378","journal-title":"Diabetes Care"},{"issue":"9","key":"2492_CR28","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s00125-019-4959-1","volume":"62","author":"S Eid","year":"2019","unstructured":"Eid S, Sas KM, Abcouwer SF, Feldman EL, Gardner TW, Pennathur S et al (2019) New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism [J]. Diabetologia 62(9):1539\u20131549","journal-title":"Diabetologia"},{"issue":"1","key":"2492_CR29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.apsb.2020.07.002","volume":"11","author":"Y Shen","year":"2021","unstructured":"Shen Y, Chen W, Han L, Bian Q, Fan J, CAO Z et al (2021) VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses [J]. Acta Pharm Sin B 11(1):127\u2013142","journal-title":"Acta Pharm Sin B"},{"issue":"9","key":"2492_CR30","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1007\/s00125-024-06191-8","volume":"67","author":"M Wu","year":"2024","unstructured":"Wu M, Yoon CY, Park J, Kim G, Nam BY, Kim S et al (2024) The role of PCSK9 in glomerular lipid accumulation and renal injury in diabetic kidney disease [J]. Diabetologia 67(9):1980\u20131997","journal-title":"Diabetologia"},{"issue":"1","key":"2492_CR31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s10020-022-00545-x","volume":"28","author":"C Zhao","year":"2022","unstructured":"Zhao C, Li L, Li C, Tang C, Cai J, Liu Y et al (2022) PACS-2 deficiency in tubular cells aggravates lipid-related kidney injury in diabetic kidney disease [J]. Mol Med 28(1):117","journal-title":"Mol Med"},{"issue":"1","key":"2492_CR32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrneph.2017.142","volume":"14","author":"K Azushima","year":"2018","unstructured":"Azushima K, Gurley SB, Coffman TM (2018) Modelling diabetic nephropathy in mice [J]. Nat Rev Nephrol 14(1):48\u201356","journal-title":"Nat Rev Nephrol"},{"key":"2492_CR33","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.2147\/DDDT.S405266","volume":"17","author":"C Tang","year":"2023","unstructured":"Tang C, Deng X, Qu J, Miao Y, Tian L, Zhang M et al (2023) Fenofibrate attenuates renal tubular cell apoptosis by Up-Regulating MCAD in diabetic kidney disease [J]. Drug Des Devel Ther 17:1503\u20131514","journal-title":"Drug Des Devel Ther"},{"key":"2492_CR34","doi-asserted-by":"crossref","first-page":"111532","DOI":"10.1016\/j.biopha.2021.111532","volume":"138","author":"H Wang","year":"2021","unstructured":"Wang H, Huang M, Bei W, Yang Y, Song L, Zhang D et al (2021) FTZ attenuates liver steatosis and fibrosis in the minipigs with type 2 diabetes by regulating the AMPK signaling pathway [J]. Biomed Pharmacother 138:111532","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2492_CR35","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13020-022-00648-x","volume":"17","author":"L Song","year":"2022","unstructured":"Song L, Wang K, Yin J, Yang Y, Li B, Zhang D et al (2022) Traditional Chinese medicine Fufang-Zhenzhu-Tiaozhi capsule prevents renal injury in diabetic minipigs with coronary heart disease [J]. Chin Med 17(1):102","journal-title":"Chin Med"},{"issue":"5","key":"2492_CR36","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1194\/jlr.M032482","volume":"54","author":"CX Huang","year":"2013","unstructured":"Huang CX, Zhang YL, Wang JF, Jiang JY, Bao JL (2013) MCP-1 impacts RCT by repressing ABCA1, ABCG1, and SR-BI through PI3K\/Akt posttranslational regulation in HepG2 cells [J]. J Lipid Res 54(5):1231\u20131240","journal-title":"J Lipid Res"},{"issue":"10","key":"2492_CR37","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41581-023-00741-w","volume":"19","author":"A Mitrofanova","year":"2023","unstructured":"Mitrofanova A, Merscher S, Fornoni A (2023) Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease [J]. Nat Rev Nephrol 19(10):629\u2013645","journal-title":"Nat Rev Nephrol"},{"key":"2492_CR38","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ebiom.2018.01.008","volume":"28","author":"N Boudaba","year":"2018","unstructured":"Boudaba N, Marion A, Huet C, Pierre R, Viollet B, Foretz M (2018) AMPK Re-Activation suppresses hepatic steatosis but its downregulation does not promote fatty liver development [J]. EBioMedicine 28:194\u2013209","journal-title":"EBioMedicine"},{"key":"2492_CR39","doi-asserted-by":"crossref","first-page":"118698","DOI":"10.1016\/j.jep.2024.118698","volume":"335","author":"Z Lin","year":"2024","unstructured":"Lin Z, Huo H, Huang M, Tao J, Yang Y, Guo J (2024) Fufang Zhenzhu Tiaozhi (FTZ) capsule ameliorates diabetic kidney disease in mice via inhibiting the SGLT2\/glycolysis pathway [J]. J Ethnopharmacol 335:118698","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"2492_CR40","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41581-022-00648-y","volume":"19","author":"C Huynh","year":"2023","unstructured":"Huynh C, Ryu J, Lee J, Inoki A, Inoki K (2023) Nutrient-sensing mTORC1 and AMPK pathways in chronic kidney diseases [J]. Nat Rev Nephrol 19(2):102\u2013122","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"2492_CR41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13293-023-00543-6","volume":"14","author":"F Juszczak","year":"2023","unstructured":"Juszczak F, Pierre L, Decarnoncle M, Jadot I, Martin B, Botton O et al (2023) Sex differences in obesity-induced renal lipid accumulation revealed by lipidomics: a role of Adiponectin\/AMPK axis [J]. Biol Sex Differ 14(1):63","journal-title":"Biol Sex Differ"},{"issue":"5","key":"2492_CR42","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jnutbio.2012.04.013","volume":"24","author":"V Soetikno","year":"2013","unstructured":"Soetikno V, Sari FR, Sukumaran V, Lakshmanan AP, Harima M, Suzuki K et al (2013) Curcumin decreases renal triglyceride accumulation through AMPK-SREBP signaling pathway in streptozotocin-induced type 1 diabetic rats [J]. J Nutr Biochem 24(5):796\u2013802","journal-title":"J Nutr Biochem"},{"key":"2492_CR43","doi-asserted-by":"crossref","first-page":"154334","DOI":"10.1016\/j.metabol.2020.154334","volume":"111","author":"X Liu","year":"2020","unstructured":"Liu X, Xu C, Xu L, Li X, Sun H, Xue M et al (2020) Empagliflozin improves diabetic renal tubular injury by alleviating mitochondrial fission via AMPK\/SP1\/PGAM5 pathway [J]. Metabolism 111:154334","journal-title":"Metabolism"},{"key":"2492_CR44","doi-asserted-by":"crossref","first-page":"110684","DOI":"10.1016\/j.biopha.2020.110684","volume":"131","author":"Y Guo","year":"2020","unstructured":"Guo Y, Ran Z, Zhang Y, Song Z, Wang L, Yao L et al (2020) Marein ameliorates diabetic nephropathy by inhibiting renal sodium glucose transporter 2 and activating the AMPK signaling pathway in Db\/db mice and high glucose-treated HK-2 cells [J]. Biomed Pharmacother 131:110684","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"2492_CR45","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2337\/db23-0811","volume":"73","author":"Y Xie","year":"2024","unstructured":"Xie Y, Yuan Q, Tang B, Xie Y, Cao Y, Qiu Y et al (2024) CPT1A protects podocytes from lipotoxicity and apoptosis in vitro and alleviates diabetic nephropathy in vivo [J]. Diabetes 73(6):879\u2013895","journal-title":"Diabetes"},{"key":"2492_CR46","doi-asserted-by":"crossref","first-page":"104778","DOI":"10.1016\/j.phrs.2020.104778","volume":"156","author":"K Su","year":"2020","unstructured":"Su K, Yi B, Yao BQ, Xia T, Yang YF, Zhang ZH et al (2020) Liraglutide attenuates renal tubular ectopic lipid deposition in rats with diabetic nephropathy by inhibiting lipid synthesis and promoting lipolysis [J]. Pharmacol Res 156:104778","journal-title":"Pharmacol Res"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-025-02492-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-025-02492-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-025-02492-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:41:17Z","timestamp":1761907277000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-025-02492-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":46,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["2492"],"URL":"https:\/\/doi.org\/10.1007\/s00592-025-02492-5","relation":{},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"5 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures involving animals were conducted in accordance with the ethical standards of the institution where the studies were performed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}}]}}